Product Information
ORIAHNN 300-1-0.5 MG/300 MG CAPS is a brand product labeled by AbbVie Inc., priced at $21.9308 per EA under NDC 00074101756. Its NADAC has been published 236 times since Sep 22, 2021.
Manufacturer
AbbVie Inc.NDC
00074101756
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA213388On Market Since
5/29/2020
Price Statistics
The NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has been published 236 times since Sep 22, 2021, and over the history we have for it it has risen 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.9308 per EA |
|---|---|
| All-time high | $21.9308 (Jun 24, 2026) |
| All-time low | $16.8370 (Sep 22, 2021) |
| 52-week high | $21.9308 |
| 52-week low | $20.7116 |
| Median price | $19.6502 |
| Average price | $19.4239 |
| Largest weekly change | +7.4% (Jan 26, 2022) |
| Weeks tracked | 236 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Elagolix and Estradiol and Norethisterone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ORIAHNN 300-1-0.5 MG/300 MG CAPS?
The current National Average Drug Acquisition Cost (NADAC) for ORIAHNN 300-1-0.5 MG/300 MG CAPS, manufactured by AbbVie Inc., is $21.9308 per EA (NDC 00074101756), effective Jun 24, 2026.
How has the price of ORIAHNN 300-1-0.5 MG/300 MG CAPS changed over time?
Over the history we have for it, the NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has risen 30.3%. It has been tracked across 236 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for ORIAHNN 300-1-0.5 MG/300 MG CAPS?
Since Sep 22, 2021, the NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has ranged from a low of $16.8370 (Sep 22, 2021) to a high of $21.9308 (Jun 24, 2026), with a median of $19.6502 per EA.
Are there cheaper alternatives to ORIAHNN 300-1-0.5 MG/300 MG CAPS?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ORIAHNN 300-1-0.5 MG/300 MG CAPS, so no direct lower-cost alternative is listed.
Who manufactures ORIAHNN 300-1-0.5 MG/300 MG CAPS?
ORIAHNN 300-1-0.5 MG/300 MG CAPS (NDC 00074101756) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification